Financials

Fierce Pharma

AbbVie will continue to pursue external innovation for long-term

Amid reports that AbbVie is angling for a $1B buyout of neuroscience specialist Gilgamesh, the company revealed booming sales of Skyrizi and Rinvoq.

Kevin Dunleavy Jul 31, 2025 11:44am

Boerner

Fierce Pharma

BMS touts commercial execution, reckons with clinical setbacks

Jul 31, 2025 11:10am

Doustdar

Fierce Pharma

Novo Nordisk names new CEO as it cuts sales, profit outlook

Jul 29, 2025 10:10am

A one dollar bill sitting next to a declining stock graph

Fierce Pharma

Vor Bio's surprise $4B revival deal splits investor reactions

Jun 26, 2025 10:55am

Man hands gold dollar sign to another man

Fierce Pharma

Bavarian Nordic's $160M PRV price reflects new realities

Jun 18, 2025 11:47am